(Scanned from the applicant's description) Type 2 diabetes mellitus is characterized by chronic hyperglycemia and is often associated with elevated plasma lipid levels. The overall objective of this proposal is to ascertain the mechanisms whereby prolonged exposure to elevated levels of fatty acids (FA) affects pancreatic beta-cell function in Type 2 diabetes. Previously, we have demonstrated that prolonged exposure to FA impairs insulin gene expression only in the presence of high glucose, and that this is associated with increased neutral lipid synthesis.
Specific Aim I : To identify the metabolic intermediate(s) generated along the pathway of neutral lipid synthesis responsible for the impairment of insulin secretion and gene expression upon prolonged exposure to FA. Isolated rat islets, HIT-T15, and betaHC-l3 cells will be cultured for 1 to 7 days in the presence of increasing concentrations of glucose and FA. Pharmacological tools will be used to inhibit or stimulate each step of neutral lipid synthesis, in order to identify the metabolic intermediate(s) generated along the esterification pathway (i.e., long-chain Acyl-CoA, diacyiglycerols, or triacylglycerols) responsible for the FA-induced impairment of beta-cell function.
Specific Aim II : To assess whether the glucose-dependent deleterious effects of prolonged exposure to elevated FA on beta-cell function are glucose-specific, and whether the mechanisms of these effects are transcriptional, post-transcriptional, or translational. beta-cell exhaustion will be distinguished from bona fide toxicity in experiments where diazoxide will be used to inhibit insulin release. The glucose-specificity of PA effects will be investigated by using a non-glucose secretagogue to stimulate insulin secretion and insulin gene expression. The glucose-dependent effects of FA on proinsulin biosynthesis, insulin mRNA stability, and endogenous insulin gene transcription will be assessed. The effects of FA on insulin promoter activity will be characterized in HIT-Tl5 and betaHC-13 cells and also investigated in primary islets using the recombinant adenovirus system.
Specific Aim III : To determine whether high-fat feeding in hyperglycemic Goto-Kakizaki (GK) rats impairs insulin secretion, insulin biosynthesis, and insulin gene expression, and whether these effects are prevented by normalization of blood glucose levels. GK or control rats will be fed a high-fat diet for 6 weeks, after which insulin secretion, proinsulin biosynthesis, and insulin gene expression will be assessed. Blood glucose levels will be normalized in GK rats by phloridzin administration, in an attempt to prevent the deleterious effects of high-fat diet on beta-cell function. These experiments will provide important insights into the pathophysiology of beta-cell dysfunction of type 2 diabetes, and have clear implications for the treatment of this disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK058096-02
Application #
6517794
Study Section
Metabolism Study Section (MET)
Program Officer
Laughlin, Maren R
Project Start
2001-06-01
Project End
2005-05-31
Budget Start
2002-06-01
Budget End
2003-05-31
Support Year
2
Fiscal Year
2002
Total Cost
$262,500
Indirect Cost
Name
Pacific Northwest Research Institute
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98122
Alquier, Thierry; Poitout, Vincent (2018) Considerations and guidelines for mouse metabolic phenotyping in diabetes research. Diabetologia 61:526-538
Moullé, Valentine S; Vivot, Kevin; Tremblay, Caroline et al. (2017) Glucose and fatty acids synergistically and reversibly promote beta cell proliferation in rats. Diabetologia 60:879-888
Moullé, Valentine S; Ghislain, Julien; Poitout, Vincent (2017) Nutrient regulation of pancreatic ?-cell proliferation. Biochimie 143:10-17
Ghislain, Julien; Fontés, Ghislaine; Tremblay, Caroline et al. (2016) Dual-Reporter ?-Cell-Specific Male Transgenic Rats for the Analysis of ?-Cell Functional Mass and Enrichment by Flow Cytometry. Endocrinology 157:1299-306
Koppe, Laetitia; Nyam, Elsa; Vivot, Kevin et al. (2016) Urea impairs ? cell glycolysis and insulin secretion in chronic kidney disease. J Clin Invest 126:3598-612
Mosser, Rockann E; Maulis, Matthew F; Moullé, Valentine S et al. (2015) High-fat diet-induced ?-cell proliferation occurs prior to insulin resistance in C57Bl/6J male mice. Am J Physiol Endocrinol Metab 308:E573-82
Oropeza, Daniel; Jouvet, Nathalie; Budry, Lionel et al. (2015) Phenotypic Characterization of MIP-CreERT1Lphi Mice With Transgene-Driven Islet Expression of Human Growth Hormone. Diabetes 64:3798-807
Oropeza, Daniel; Jouvet, Nathalie; Bouyakdan, Khalil et al. (2015) PGC-1 coactivators in ?-cells regulate lipid metabolism and are essential for insulin secretion coupled to fatty acids. Mol Metab 4:811-22
Fontés, Ghislaine; Ghislain, Julien; Benterki, Isma et al. (2015) The ?F508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Is Associated With Progressive Insulin Resistance and Decreased Functional ?-Cell Mass in Mice. Diabetes 64:4112-22
Semache, Meriem; Ghislain, Julien; Zarrouki, Bader et al. (2014) Pancreatic and duodenal homeobox-1 nuclear localization is regulated by glucose in dispersed rat islets but not in insulin-secreting cell lines. Islets 6:e982376

Showing the most recent 10 out of 39 publications